Agios Pharmaceuticals - Company Information
We're focused on discovering and developing novel investigational medicines to treat genetically defined diseases through scientific leadership in the field of cellular metabolism. our most advanced drug candidate is a first-in-class pyruvate kinase r (pkr) activator, mitapivat, that is currently being evaluated for the treatment of three distinct hemolytic anemias. in addition to our active late-stage clinical pipeline, we have multiple novel, investigational therapies in clinical and preclinical development. we're a company that cares about our work, each other, and the people who are counting on us the most. we're inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.
Pharmaceuticals
Agios Pharmaceuticals - Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by Sprouts.ai, used by Agios Pharmaceuticals.
Materialize
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Javascript
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Vue.js
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
TweenMax
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Polyfill
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
PHP
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Employee profile
John Doe
CEO
Samantha Duncan
CTO
Gary Austin
MD
Jonathan Shaw
CMD
Janice May
MD
Janet McDonald
CFO
Agios Pharmaceuticals - Company Information
We're focused on discovering and developing novel investigational medicines to treat genetically defined diseases through scientific leadership in the field of cellular metabolism. our most advanced drug candidate is a first-in-class pyruvate kinase r (pkr) activator, mitapivat, that is currently being evaluated for the treatment of three distinct hemolytic anemias. in addition to our active late-stage clinical pipeline, we have multiple novel, investigational therapies in clinical and preclinical development. we're a company that cares about our work, each other, and the people who are counting on us the most. we're inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.
Pharmaceuticals
Agios Pharmaceuticals - Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by Sprouts.ai, used by Agios Pharmaceuticals.
Materialize
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Javascript
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Vue.js
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
TweenMax
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Polyfill
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
PHP
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Employee profile
John Doe
CEO
Samantha Duncan
CTO
Gary Austin
MD
Jonathan Shaw
CMD
Janice May
MD
Janet McDonald
CFO
